Every year, World Multiple Sclerosis (MS) Day is observed globally on May 30. Sponsored by the MS International Federation (MSIF), this campaign aims to generate global awareness about multiple sclerosis and to support and connect the people living with this chronic neurological disorder worldwide. It is a day to celebrate global solidarity and hope for the future. Multiple sclerosis (MS) is a potentially disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. The exact cause of multiple sclerosis is unknown. The condition can cause permanent damage or deterioration of the nerves. Signs and symptoms of MS vary widely and depend on the extent of nerve damage and which nerves are affected. There is no specific cure for MS. However, complementary treatment modalities can help modify the course of the disease and manage symptoms. For correct clinical documentation of this brain and spine disorder, physicians can consider utilizing medical billing and coding services.

Reports suggest that multiple sclerosis affects about 400,000 people in the United States, and about 2.5 million worldwide. The prevalence of this condition in the United States is nearly 90 cases per 100,000 people. The signs and symptoms of MS may differ greatly from person to person and over the course of the disease depending on the location of the affected nerve fibers. Common symptoms include numbness/weakness (in one or more limbs), muscle weakness, complete or partial loss of vision, slurred speech, difficulties with co-ordination and balance, fatigue, dizziness, tingling or pain in parts of your body and problems with thinking and memory.

The 2019 campaign aims to challenge the common misconceptions associated with MS and highlight the different ways on how to provide the right support to affected people. Experts believe that a combination of environmental and genetic factors contribute to the risk of developing MS. The condition can occur at any age; however, most people diagnosed come in the age group of 20 – 50 years, with at least two to three times more women than men being diagnosed with the disease.

As there is no specific test to correctly diagnose this condition, physicians may generally begin their diagnosis with a detailed physical examination and evaluation of previous medical history. Diagnostic imaging tests such as lumbar puncture (spinal tap), evoked potential tests, Magnetic Resonance Imaging (MRI) and blood tests will also be performed as part of the diagnosis. Treatment options for this chronic neurological condition include – medications, corticosteroids, plasma exchange (plasmapheresis), muscle relaxants and physical therapy exercises to reduce prominent symptoms like pain, and bladder or bowel control problems related to this condition. The diagnosis tests and other treatment procedures performed by neurologists and other physicians must be carefully documented using the correct medical codes. Medical coding services offered by reputable medical billing and coding companies can help physicians use the correct codes for their billing purposes. ICD-10-CM codes for diagnosing Multiple Sclerosis (MS) include –

  • G35 – Multiple sclerosis
  • G36 – Other acute disseminated demyelination
    • G36.0 – Neuromyelitis optica [Devic]
    • G36.1 – Acute and sub acute hemorrhagic leukoencephalitis [Hurst]
    • G36.8 – Other specified acute disseminated demyelination
    • G36.9 – Acute disseminated demyelination, unspecified
  • G37 – Other demyelinating diseases of central nervous system
    • G37.0 – Diffuse sclerosis of central nervous system
    • G37.1 – Central demyelination of corpus callosum
    • G37.2 – Central pontine myelinolysis
    • G37.3 – Acute transverse myelitis in demyelinating disease of central nervous system
    • G37.4 – Sub-acute necrotizing myelitis of central nervous system
    • G37.5 – Concentric sclerosis [Balo] of central nervous system
    • G37.8 – Other specified demyelinating diseases of central nervous system
    • G37.9 – Demyelinating disease of central nervous system, unspecified

    First initiated in the year 2009 by the MS International Federation (MSIF), the World Multiple Sclerosis (MS) Day aims to reach hundreds of thousands of people around the world, with a specific campaign focusing on a different theme each year. The theme for the 2019 one-day event is “Visibility” and the campaign is called “My Invisible MS” (#MyInvisibleMS). The My Invisible MS campaign is all about generating widespread public awareness about the invisible symptoms of MS and the unseen impact of MS on the quality of life. The campaign offers a unique platform to all people affected by MS to voice their opinion, share the invisible symptoms they experience, challenge common misconceptions about the condition and provide the right support to the affected people. MSIF provides a toolkit of free resources to help everyone take part in “World MS Day”.

    Join World Multiple Sclerosis (MS) Day Campaign on May 30! Spread awareness about this brain and spine disorder, its symptoms and treatment options.